Verdin; Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for Verdin; Eric.The latest application filed is for "compositions and methods for reactivating latent immunodeficiency virus and/or treating immunodeficiency virus infection".

Company Profile

7.9.18

Verdin; Eric - San Francisco CA
Verdin; Eric - Mill Valley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Reactivating Latent Immunodeficiency Virus And/or Treating Immunodeficiency Virus Infection App 20220193209 - Gracia; Albert Vallejo ; et al.	2022-06-23
Medium Chain Fatty Acid Esters Of Beta-hydroxybutyrate And Butanediol And Compositions And Methods For Using Same App 20210171432 - Verdin; Eric ; et al.	2021-06-10
Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same Grant 10,889,538 - Verdin , et al. January 12, 2	2021-01-12
Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same Grant 10,647,658 - Verdin , et al.	2020-05-12
S-enantiomers Of Beta-hydroxybutyrate And Butanediol And Methods For Using Same App 20200140371 - Verdin; Eric ; et al.	2020-05-07
Medium chain fatty acid esters of .beta.-hydroxybutyrate and butanediol and compositions and methods for using same Grant 10,562,839 - Verdin , et al. Feb	2020-02-18
Medium Chain Fatty Acid Esters Of Beta-hydroxybutyrate And Butanediol And Compositions And Methods For Using Same App 20190382333 - Verdin; Eric ; et al.	2019-12-19
Medium Chain Fatty Acid Esters Of Beta-hydroxybutyrate And Butanediol And Compositions And Methods For Using Same App 20190359551 - Verdin; Eric ; et al.	2019-11-28
Medium Chain Fatty Acid Esters Of Beta-hydroxybutyrate And Butanediol And Compositions And Methods For Using Same App 20190248730 - Verdin; Eric ; et al.	2019-08-15
Methods of Identifying Modulators of Dephosphorylation of Histone Deacetylase App 20150024955 - Verdin; Eric ; et al.	2015-01-22
Regulation of protein activity by reversible acetylation Grant 8,518,635 - Schwer , et al. August 27, 2	2013-08-27
Methods of modulating bromodomains App 20120028912 - Zhou; Ming-Ming ; et al.	2012-02-02
Cell Lines With Latent Immunodeficiency Virus And Methods Of Use Thereof App 20090306131 - VERDIN; Eric ; et al.	2009-12-10
ZA loops of bromodomains Grant 7,589,167 - Zhou , et al. September 15, 2	2009-09-15
Regulation of Protein Activity By Reversible Acetylation App 20090061015 - Schwer; Bjoern ; et al.	2009-03-05
Histone deacetylase and methods of use thereof Grant 7,488,587 - Verdin , et al. February 10, 2	2009-02-10
Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides Grant 7,482,016 - Doerr , et al. January 27, 2	2009-01-27
Histone Deacetylase And Methods Of Use Thereof App 20080233581 - VERDIN; ERIC ; et al.	2008-09-25
Dephosphorylation of HDAC7 By Myosin Phosphatase App 20080200566 - Verdin; Eric ; et al.	2008-08-21
Cell Lines With Latent Immunodeficiency Virus And Methods Of Use Thereof App 20080038716 - VERDIN; Eric ; et al.	2008-02-14
Cell lines with latent immunodeficiency virus and methods of use thereof Grant 7,232,685 - Verdin , et al. June 19, 2	2007-06-19
Acetylated Tat polypeptides and methods of use thereof App 20040247614 - Dorr, Alexander P. ; et al.	2004-12-09
Methods of identifying modulators of bromodomains App 20040043378 - Zhou, Ming-Ming ; et al.	2004-03-04
Methods of identifying modulators of bromodomains App 20040009613 - Zhou, Ming-Ming ; et al.	2004-01-15
Cell lines with latent immunodeficiency virus and methods of use thereof App 20030157693 - Verdin, Eric ; et al.	2003-08-21
Histone deacetylase and methods of use thereof App 20030143712 - Verdin, Eric ; et al.	2003-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.